Yes, zanpar, this is really good news. It took some time, and some pressure, but we've finally gotten the big guns to realize that this study needed to get done. The science makes sense, the pre-clinical trials have all been successful, the recent research on c-abl and TKIs, and the Georgetown proof-of-concept trial all support the need for further investigation of Nilotinib in a controlled clinical trial.

Coincidentally, the Georgetown study results were finally published today. See my post on that thread for the publication link.